Issued Patents All Time
Showing 25 most recent of 51 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12398207 | Heterodimeric antibodies that bind CD3 and CLDN6 | Matthew S. Faber, Sung-Hyung Lee, Yoon Kyung Kim, Jing Qi, Kendra N. Avery +4 more | 2025-08-26 |
| 12359002 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2025-07-15 |
| 12180302 | Heterodimeric antibodies that bind fibroblast activation protein | John Desjarlais, Alex Nisthal | 2024-12-31 |
| 12129309 | Heterodimeric antibodies that bind CD3 and CD38 | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal | 2024-10-29 |
| 11945880 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2024-04-02 |
| 11859011 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2024-01-02 |
| 11840579 | Bispecific antibodies that bind to CD38 and CD3 | Matthew Bernett, Gregory Moore, John Desjarlais | 2023-12-12 |
| 11739144 | Heterodimeric antibodies that bind CD3 and CLDN6 | Matthew S. Faber, Sung-Hyung Lee, Yoon Kyung Kim, Jing Qi, Kendra N. Avery +4 more | 2023-08-29 |
| 11673972 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2023-06-13 |
| 11623957 | Heterodimeric antibodies that bind CD3 and PSMA | Gregory Moore, John Desjarlais | 2023-04-11 |
| 11618788 | Optimized antibodies that target CD19 | Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more | 2023-04-04 |
| 11566080 | Compositions and methods for treating IgE-mediated disorders | John Desjarlais, Holly M. Horton, Matthew Bernett | 2023-01-31 |
| 11472890 | Heterodimeric antibodies that bind ENPP3 and CD3 | Rumana Rashid, Umesh Muchhal, Gregory Moore, Alex Nisthal, Sung-Hyung Lee +1 more | 2022-10-18 |
| 11447552 | Methods and compositions for inhibiting CD32B expressing cells | John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Gregory Moore, Igor Vostiar | 2022-09-20 |
| 11434295 | Methods and compositions for inhibiting CD32B expressing cells | John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Gregory Moore, Igor Vostiar | 2022-09-06 |
| 11352442 | Heterodimeric antibodies that bind CD3 and CD38 | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal | 2022-06-07 |
| 11225528 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2022-01-18 |
| 11111315 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2021-09-07 |
| 11091548 | Modulation of T cells with bispecific antibodies and Fc fusions | Matthew Bernett, Dilki Wickramarachichi, John Desjarlais | 2021-08-17 |
| 10982006 | Heterodimeric antibodies that bind fibroblast activation protein | John Desjarlais, Alex Nisthal | 2021-04-20 |
| 10913803 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2021-02-09 |
| 10889653 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2021-01-12 |
| 10858451 | Bispecific antibodies that bind to CD38 and CD3 | Matthew Bernett, Gregory Moore, John Desjarlais | 2020-12-08 |
| 10626182 | Optimized antibodies that target CD19 | Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more | 2020-04-21 |
| 10544187 | Targeting regulatory T cells with heterodimeric proteins | Matthew Bernett, Dilki Wickramarachchi, John Desjarlais | 2020-01-28 |